Retinal detachment in retinitis pigmentosa.
genetics
retina
treatment surgery
vision
vitreous
Journal
BMJ open ophthalmology
ISSN: 2397-3269
Titre abrégé: BMJ Open Ophthalmol
Pays: England
ID NLM: 101714806
Informations de publication
Date de publication:
2020
2020
Historique:
received:
12
02
2020
revised:
23
04
2020
accepted:
03
06
2020
entrez:
17
7
2020
pubmed:
17
7
2020
medline:
17
7
2020
Statut:
epublish
Résumé
Retinitis pigmentosa-related retinal detachment (RPRD) is rare, and the full spectrum of retinal complications is not well defined. To describe the types of retinal detachment in patients with retinitis pigmentosa and the surgical outcomes of RPRD. This is a non-comparative, retrospective case series. An electronic database search was performed using Moorfields OpenEyes electronic health records. We identified 90 patients with RPRD between January 2000 and August 2017. Main outcome and measures are visual acuity (VA), surgical outcomes and classification of RPRD. Of the 90 patients/detachments, 61 (67.8%) were rhegmatogenous retinal detachment (RRD), 19 (21.1%) were exudative, 3 (3.3%) were tractional retinal detachment (TRD) and 7 (7.8%) had combined. 37.5% (9/24) of patients with exudative retinal detachment were treated with either cryotherapy or laser, and one patient underwent vitrectomy for vitreous haemorrhage. 56/90 patients underwent surgical intervention. Nine patients presented late and were deemed inoperable (two exudative and seven RRD). Of the RRD patients with full operative record, the primary attachment rate was 76.2% (16/21) and final reattachment rate was 85.7% (18/21) over a mean 15.4-year follow-up period. Mean VA for RRD surgery improved from 6/190 (1.51 logMAR) to 6/120 (1.31 logMAR) (p=0.194). In the TRD group, the mean VA was 6/300 (1.66 logMAR) at baseline and improved after surgery to 6/48 (0.90 logMAR) (p=0.421). We demonstrated a final reattachment rate of 85.7% with a trend toward better vision following intervention for patients with RPRD. However, the final long-term vision may be poor due to the natural progression of retinitis pigmentosa-associated macular degeneration.
Identifiants
pubmed: 32671228
doi: 10.1136/bmjophth-2020-000454
pii: bmjophth-2020-000454
pmc: PMC7351280
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e000454Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Prog Retin Eye Res. 1998 Apr;17(2):175-205
pubmed: 9695792
Am J Hum Genet. 2001 Jul;69(1):198-203
pubmed: 11389483
Ophthalmologica. 1996;210(2):104-7
pubmed: 9148254
Br J Ophthalmol. 2000 Dec;84(12):1372-5
pubmed: 11090475
Nat Rev Cardiol. 2015 May;12(5):312-6
pubmed: 25781411
Retina. 2011 Mar;31(3):492-6
pubmed: 21102367
BMC Ophthalmol. 2013 Jul 16;13(1):33
pubmed: 23855829
Am J Ophthalmol. 1974 May;77(5):619-49
pubmed: 4823775
Invest Ophthalmol Vis Sci. 1977 Oct;16(10):947-62
pubmed: 908648
Ophthalmol Retina. 2018 Jan;2(1):10-16
pubmed: 31047295
Ophthalmic Surg. 1995 Jan-Feb;26(1):34-8
pubmed: 7746622
Retina. 2017 Jan;37(1):161-172
pubmed: 27380427
Hum Mutat. 2012 Feb;33(2):306-15
pubmed: 22065545
Trans Am Ophthalmol Soc. 1983;81:693-735
pubmed: 6676982
Semin Ophthalmol. 2013 Sep-Nov;28(5-6):397-405
pubmed: 24138049
Invest Ophthalmol Vis Sci. 2003 Feb;44(2):848-55
pubmed: 12556421
Retina. 2016 Jul;36(7):1345-8
pubmed: 26655616
Invest Ophthalmol Vis Sci. 2011 Feb 23;52(2):994-1002
pubmed: 20861493
Trans Am Acad Ophthalmol Otolaryngol. 1972 Mar-Apr;76(2):480-97
pubmed: 4582684
Ophthalmology. 2017 Jun;124(6):884-895
pubmed: 28341475
Ophthalmology. 1982 Dec;89(12):1425-32
pubmed: 7162785
Br J Ophthalmol. 1978 Mar;62(3):163-7
pubmed: 638108
Ophthalmology. 1995 May;102(5):805-16
pubmed: 7777280